|Bid||23.21 x 800|
|Ask||28.21 x 800|
|Day's Range||25.59 - 26.05|
|52 Week Range||19.20 - 35.37|
|Beta (3Y Monthly)||1.31|
|PE Ratio (TTM)||63.36|
|Earnings Date||May 6, 2019 - May 10, 2019|
|Forward Dividend & Yield||0.24 (0.94%)|
|1y Target Est||29.60|
AUSTIN, Texas , Feb. 8, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the first quarter of ...
Luminex (LMNX) delivered earnings and revenue surprises of -66.67% and 2.63%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
The Austin, Texas-based company said it had a loss of 5 cents per share. Earnings, adjusted for costs related to mergers and acquisitions and pretax expenses, were 4 cents per share. The results did not ...
AUSTIN, Texas , Feb. 4, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full-year 2018. Financial and operating highlights for the quarter ...
Luminex (LMNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be remiss not to mention that insider sales have Read More...
Luminex (LMNX) gains from strength in the Aries platform. However, cutthroat competition in the life sciences industry is worrisome.
AUSTIN, Texas, Jan. 7, 2019 /PRNewswire/ -- Luminex Corporation (LMNX) today announced that it expects its revenues in the fourth quarter of 2018 to be approximately $81 million and to exceed $315 million for the full- year ended 2018, near the top of the previously communicated guidance range of $310 to $316 million. Total MDx revenue of approximately $164 million, up 1% over the full year 2017, inclusive of the departure of approximately $13 million of LabCorp non-CF revenue. Total MDx revenue was up by approximately 13%, excluding the departure of LabCorp.
It's been a wild ride on Wall Street this year but a few Austin companies found a way to buck the general downward trend of the stock market.
AUSTIN, Texas, Jan. 2, 2019 /PRNewswire/ -- Luminex Corporation (LMNX) today announced that the company has completed its previously announced acquisition of MilliporeSigma's flow cytometry portfolio for $75 million in combined stock, asset and inventory purchases. The acquisition is expected to contribute $40 million to $50 million in revenue to Luminex in 2019. "We are pleased to announce the completion of this transaction and excited to welcome the talented MilliporeSigma flow cytometry team to the Luminex family," said Homi Shamir, president and CEO of Luminex.
Luminex Corporation (NASDAQ:LMNX), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is LMNX will Read More...
AUSTIN, Texas, Dec. 11, 2018 /PRNewswire/ -- Luminex Corporation (LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the fourth quarter of 2018 of $0.06 per share of common stock payable on January 10, 2019 to stockholders of record as of the close of business December 20, 2018. At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. To learn more about Luminex, please visit us at www.luminexcorp.com.
NEW YORK, Dec. 11, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Luminex (LMNX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...
On a per-share basis, the Austin, Texas-based company said it had profit of 4 cents. Earnings, adjusted for costs related to mergers and acquisitions and severance costs, came to 5 cents per share. The ...